Abstract:Background and Purpose Chronic inflammation plays a pivotal role in the development of Type 2 diabetes mellitus (T2DM). Previous studies have shown that haem oxygenase‐1 (HO‐1) plays a proinflammatory role during metabolic stress, suggesting that HO‐1 inhibition could be an effective strategy to treat T2DM. However, the application of HO‐1 inhibitors is restricted due to solubility‐limited bioavailability. In this study, we encapsulated the HO‐1 inhibitor, zinc protoporphyrin IX (ZnPP), within nanoparticles and investigated their role in regulating glucose homeostasis and chronic inflammation during obesity. Experimental Approach We delivered DMSO‐dissolved ZnPP (DMSO‐ZnPP) and ZnPP‐laden nanoparticles (Nano‐ZnPP) to diet‐induced obese male mice for 6 weeks. Glucose and insulin tolerance tests were carried out, liver and adipose tissue gene expression profiles analysed, and systemic inflammation analysed using flow cytometry. Key Results Nanoparticles significantly increased the delivery efficiency of ZnPP in both cells and mice. In mice with diet‐induced obesity, inhibition of HO‐1 by Nano‐ZnPP significantly decreased adiposity, increased insulin sensitivity, and improved glucose tolerance. Moreover, Nano‐ZnPP treatment attenuated both local and systemic inflammatory levels during obesity. Mechanistically, Nano‐ZnPP significantly attenuated glucagon, TNF, and fatty acid synthesis signalling pathways in the liver. In white adipose tissue, the oxidative phosphorylation signalling pathway was enhanced and the inflammation signalling pathway diminished by Nano‐ZnPP. Our results show that Nano‐ZnPP has better effects on the improvement of glucose homeostasis and attenuation of chronic inflammation, than those of DMSO‐dissolved ZnPP. Conclusions and Implications These findings indicate that ZnPP‐laden nanoparticles are potential therapeutic agents for treating T2DM.

Sub-nanosized vanadate hybrid clusters maintain glucose homeostasis and restore treatment response in inflammatory disease in obese mice

Reducing obesity and inflammation in mice with organically-derivatized polyoxovanadate clusters

Insulin‐Sensitizing Activity of Sub‐Nanoscaled Polyalkoxyvanadate Clusters

Inhibition of mitogen-activated protein kinases/nuclear factor κB-dependent inflammation by a novel chalcone protects the kidney from high fat diet-induced injuries in mice.

A Guanidine-Rich Regulatory Oligodeoxy-Nucleotide Improves Type-2 Diabetes in Obese Mice by Blocking T-Cell Differentiation

Fucoidans from Pearsonothuria Graeffei Prevent Obesity by Regulating Intestinal Lipid Metabolism and Inflammation Related Signalling Pathways

ZnPP‐laden nanoparticles improve glucose homeostasis and chronic inflammation during obesity

A novel long-acting oxyntomodulin analogue eliminates diabetes and obesity in mice

Oleanolic Acid Improves Obesity-Related Inflammation and Insulin Resistance by Regulating Macrophages Activation

Impact of A Cargo-Less Liposomal Formulation on Dietary Obesity-Related Metabolic Disorders in Mice

Treatment of Obesity-Related Inflammation with a Novel Synthetic Pentacyclic Oleanane Triterpenoids Via Modulation of Macrophage Polarization

Anti-Obesity Activity of Sanghuangporus vaninii by Inhibiting Inflammation in Mice Fed a High-Fat Diet

Polyalkoxyvanadates: Insulin‐Sensitizing Activity of Sub‐Nanoscaled Polyalkoxyvanadate Clusters (adv. Biosys. 5/2020)

Enhanced purinergic signaling in the paraventricular hypothalamus induces hyperphagic obesity and insulin resistance

Atomically Precise Gold Nanoclusters As ROS-scavenging Clusterzymes to Treat High-Fat Diet-Induced Obesity

Low-intensity pulsed ultrasound improves metabolic dysregulation in obese mice by suppressing inflammation and extracellular matrix remodeling

Polydextrose Alleviates Adipose Tissue Inflammation and Modulates the Gut Microbiota in High-Fat Diet-Fed Mice

Unsaturated alginate oligosaccharides attenuated obesity-related metabolic abnormalities by modulating gut microbiota in high-fat-diet mice

Low-intensity Pulsed Ultrasound Attenuates Body Weight and Insulin Resistance in Obese Mice Induced by High-Fat Diet

Octacosanol Modifies Obesity, Expression Profile and Inflammation Response of Hepatic Tissues in High-Fat Diet Mice

Treatment of Obesity and Diabetes Using Oxytocin or Analogs in Patients and Mouse Models.